Antitumour vaccination via the targeted proteolysis of antigens isolated from tumour lysates
{{output}}
The activation of cytotoxic T cells against tumour cells typically requires the cross-presentation, by antigen-presenting cells (and via major histocompatibility complex class I molecules), of an epitope derived from a tumour antigen. A critical step in antige... ...
